Keyphrases
Enterohemorrhagic Escherichia Coli
100%
Gold Nanoparticles
100%
Nanoparticle Vaccine
100%
Au Nanoparticles (AuNPs)
60%
Escc
50%
Immunogenicity
20%
Escherichia Coli
20%
IgG Titer
20%
Synthetic Nanoparticles
20%
Nanovaccine
20%
Public Health Risk
10%
Diarrhea
10%
Extraintestinal Pathogenic E. Coli (ExPEC)
10%
Atypical Hemolytic Uremic Syndrome (aHUS)
10%
Subunit Vaccine
10%
Vaccine Development
10%
Secretory Immunoglobulin A (SIgA)
10%
Effective Intervention
10%
Human Infection
10%
Outer Membrane Protein
10%
Disease Model
10%
Human Use
10%
Causative Agents
10%
Type 3 Secretion System (T3SS)
10%
Human Pathogens
10%
Antigen-specific
10%
Intestinal Colonization
10%
Bacteriophage
10%
Public Safety
10%
Titer
10%
Feces
10%
Nanoparticles
10%
Antibiotic Use
10%
Enteroaggregative E. Coli
10%
Human Intestinal Epithelial Cells
10%
Serum IgA
10%
Outer Membrane
10%
Enteric Pathogens
10%
Serum IgG
10%
Subcutaneous Immunization
10%
Public Health Interventions
10%
Classical Complement Pathway
10%
Hemorrhagic Colitis
10%
Escherichia Coli Infections
10%
Gold Nanoparticles(AuNPs)
10%
Escherichia Coli O157:H7 Strain
10%
Global Public Health
10%
Immunogenic Antigens
10%
Safety Control Measures
10%
Natural Properties
10%
Stable Formulations
10%
Recurrent Outbreaks
10%
Pharmacology, Toxicology and Pharmaceutical Science
Escherichia Coli O157
100%
Gold Nanoparticle
100%
Enterohemorrhagic Escherichia Coli
100%
Nanoparticle
30%
Immunogenicity
20%
Escherichia coli
20%
Nanovaccine
20%
Diseases
20%
Infection
10%
Infectious Agent
10%
Antibiotics
10%
Diarrhea
10%
Hemolytic Uremic Syndrome
10%
Subunit Vaccine
10%
Secretory Immunoglobulin
10%
Disease Model
10%
Enteropathogenic Escherichia Coli
10%
Enteroaggregative Escherichia Coli
10%
Outer Membrane Protein
10%
Hemorrhagic Colitis
10%
Escherichia Coli Infection
10%
Bacteriophage
10%
Immunology and Microbiology
Escherichia Coli O157:H7
100%
Enterohemorrhagic Escherichia Coli
100%
Titer
30%
Immunogenicity
20%
Outer Membrane
20%
Escherichia coli
20%
Infection
20%
Bacteriophage
10%
Infectious Agent
10%
Human Pathogen
10%
Subunit Vaccine
10%
Antigen Specificity
10%
Type Three Secretion System
10%
Enteropathogenic Escherichia Coli
10%
Colitis
10%
Secretory Immunoglobulin
10%
Feces
10%
Bactericidal Activity
10%
Enteroaggregative Escherichia Coli
10%
Classical Complement Pathway
10%